The action follows November's regulatory guidelines to stamp out monopolies in active pharmaceutical ingredients . China leads the world in making and exporting these products.In a statement, the ministry of industry and information technology said it would "strengthen law enforcement against unfair competition, and resolutely investigate unfair competitive acts, such as commercial bribery".
It will also stiffen enforcement of anti-monopoly laws in the areas of drug shortages and APIs, prepare and adopt antitrust guidelines in the API market and investigate monopolistic pacts, it added.Reporting by Emily Chow; Editing by Clarence Fernandez and Gerry Doyle
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más: